Stocksigma LogoStocksigma Logo

Zydus Lifesciences Reports Q2 FY27 Results with 29% Revenue Growth

Zydus Lifesciences reported consolidated revenue of Rs. 79,096 mn for Q2 FY27, up 29.2% YoY, supported by India Formulations (+18.3% YoY to Rs

Zydus Lifesciences Reports Q2 FY27 Results with 29% Revenue Growth

Zydus Lifesciences Ltd 路 Press Release 路 04 Nov 2026, 6:10 pm

Zydus Lifesciences Reports Q2 FY27 Results with 29% Revenue Growth Zydus Lifesciences reported consolidated revenue of Rs. 79,096 mn for Q2 FY27, up 29.2% YoY, supported by India Formulations (+18.3% YoY to Rs. 18,844 mn) and North America Formulations (+20.8% YoY to Rs. 33,145 mn). EBITDA declined 6.0% YoY to Rs. 18,945 mn, with margins contracting to 24.0% from 32.9% in Q2 FY26. Net profit dropped 26.6% YoY to Rs. 9,255 mn. R&D investments stood at Rs. 6,573 mn (8.3% of revenues). Net debt to EBITDA reached 0.62x as of 30th Sep'26.

Original exchange filing (PDF)

More announcements from Zydus Lifesciences Ltd

All Zydus Lifesciences Ltd announcements